Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit
暂无分享,去创建一个
Michael W. Berns | Lih-Huei L. Liaw | M. Berns | K. A. Rich | L. Liaw | C. G. Wong | H. Hsu | C.G. Wong | K.A. Rich | Hung T. Hsu
[1] J. Folkman,et al. Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .
[2] S. Bressler,et al. Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye. , 1998, Current opinion in ophthalmology.
[3] Lois E. H. Smith,et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[4] E S Gragoudas,et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.
[5] D. Hinton,et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. , 1996, Investigative ophthalmology & visual science.
[6] S. Seregard,et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. , 1996, Investigative ophthalmology & visual science.
[7] Zhongping Chen,et al. Optical Doppler Tomography: Imaging in vivo Blood Flow Dynamics Following Pharmacological Intervention and Photodynamic Therapy , 1998, Photochemistry and photobiology.
[8] P. Campochiaro,et al. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. , 1998, Experimental eye research.
[9] J. Hollyfield,et al. Basic fibroblast growth factor (bFGF) immunolocalization in the rodent outer retina demonstrated with an anti-rodent bFGF antibody , 1992, Brain Research.
[10] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[11] A. Patz. Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture. , 1982, American journal of ophthalmology.
[12] E. Keshet,et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[13] E. Stefánsson,et al. Retinal vasoconstriction after laser treatment for diabetic macular edema. , 1993, American journal of ophthalmology.
[14] A. Milam,et al. A gradient of basic fibroblast growth factor in rod photoreceptors in the normal human retina , 1997, Visual Neuroscience.
[15] G. Brown,et al. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. , 1990, Archives of ophthalmology.
[16] W. Tasman,et al. Cryotherapy for active retinopathy of prematurity. , 1986, Ophthalmology.
[17] Georg Breier,et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.
[18] E. Kohner,et al. Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. , 1996, The British journal of ophthalmology.
[19] M. Lavail,et al. Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[20] W. Benedict,et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.
[21] Einar Stefánsson,et al. Retinal vessel dilatation and elongation precedes diabetic macular oedema , 1997, The British journal of ophthalmology.
[22] George A. Williams,et al. Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. , 1987, American journal of ophthalmology.
[23] Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. , 1986, Archives of ophthalmology.
[24] G. Chader,et al. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Hatchell,et al. An experimental model of preretinal neovascularization in the rabbit. , 1991, Investigative ophthalmology & visual science.
[26] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[27] P. D'Amore,et al. Mechanisms of retinal and choroidal neovascularization. , 1994, Investigative ophthalmology & visual science.
[28] Z. Nie,et al. Retinal degeneration in transgenic mice with photoreceptor-specific expression of a dominant-negative fibroblast growth factor receptor , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[29] C. Distler,et al. Müller cells in vascular and avascular retinae: A survey of seven mammals , 1992, The Journal of comparative neurology.
[30] R Hiller,et al. Blindness caused by diabetic retinopathy. , 1974, American journal of ophthalmology.
[31] R. Frank,et al. On the pathogenesis of diabetic retinopathy. , 1984, Ophthalmology.
[32] D. Eliott,et al. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. , 1996, American journal of ophthalmology.
[33] P. Campochiaro,et al. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. , 1998, The American journal of pathology.
[34] J. Tombran-Tink,et al. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. , 1991, Experimental eye research.
[35] Lois E. H. Smith,et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[36] L. Aiello,et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Dacheux,et al. Antigenic changes of rabbit retinal Müller cells in culture. , 1998, Investigative ophthalmology & visual science.
[38] R. Engerman,et al. Pathogenesis of Diabetic Retinopathy , 1989, Diabetes.